Cyclosporine A (CsA) has been reported to positively influence hepatic compensatory growth (HCG) in normal animals. The role of calcium in the CsA-mediated influence on HCG was studied in normal and in chronically hypocalcemic rats, a model in which HCG is perturbed. CsA (3.33 mg/kg/day for 10 days) was administered before 2/3 partial hepatectomy (PHx). CsA did not influence serum Ca 2ϩ but significantly increased concentrations of the vitamin D hormone calcitriol. After PHx in normal animals, CsA accelerated DNA synthesis without influencing liver weight restitution, suggesting that its main effect was to mediate an accelerated progression through the cell cycle G 0 to G 1 /S phase(s). In hypocalcemic rats, CsA did not influence DNA synthesis, but normalization of circulating calcium alone accelerated DNA synthesis but abrogated the stimulatory effect of CsA, indicating that CsA could not superimpose its stimulatory effect on the calcium effect. In vitro investigation on the CsA mechanisms of action revealed a dose-dependent increase in hepatocyte basal resting cytoplasmic Ca 2ϩ and an increase in inositol-1,4,5-trisphosphate-sensitive Ca 2ϩ pool, which was dependent on the presence of normal extracellular Ca 2ϩ during CsA exposure. CsA also mediated a significant increase in cellular Ca 2ϩ mobilization by phenylephrine, vasopressin, and epidermal growth factor (EGF) in the presence of extracellular Ca 2ϩ concentration. Our data, therefore, demonstrate that CsA accelerates HCG after PHx by, in part, increasing the cellular Ca 2ϩ pools and the response to EGF and Ca 2ϩ -mobilizing hormones known to be comitogens for hepatocytes.
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The structurally unrelated immunosuppressants cyclosporine A (CsA) and tacrolimus (FK506) have both been proposed as positive modulators of the compensatory growth process after partial hepatectomy (PHx) in the rat, mouse, and dog (Garcia-Alonso et al., 1989; Francavilla et al., 1990; Kahn et al., 1990; Mazzaferro et al., 1990; Tanaka et al., 1993) . However, CsA has been shown to lead to either cell proliferation, cell cycle arrest, or cell death in different cell types or organs, but its mechanisms of action have not yet been fully elucidated and the dual potential of CsA on cell cycle progression remains a paradox.
Present literature suggests that the apparent stimulatory effect of CsA on normal compensatory growth seems to be largely confined to the liver. Indeed, Francavilla et al. (1990) in a study on hepatocytes, kidney, and intestine were unable to identify any influence of the drug on the hyperplastic response of either the contralateral kidney after unilateral nephrectomy, or on the small intestine after partial resection. However, despite numerous reports indicating an increase in the hepatic regeneration phenomenon induced by CsA, several studies have noted that the liver weight restitution was not influenced by the drug at 3 or 7 days after surgery (Makowka et al., 1986; Kahn et al., 1990) . It has also been suggested that CsA might have a "priming"-like effect on the liver because in the unhepatectomized rat, parameters indicative of putative regeneration processes such as increases in the hepatic content of ornithine decarboxylase, thymidine kinase, and the estrogen receptor have been observed (Kahn et al., 1990) . Moreover, a study carried out in our laboratory has indicated that at the critical time of greatest loss in liver mass, CsA has only a selective influence on the biotransformation of cytochrome P450-dependent activities (Provencher et al., 1999) . This observation indicates that the effect of CsA on the regeneration process does not translate into an overall accelerated recovery of the hepatic drugmetabolizing function.
It has now been well documented that hypocalcemia and vitamin D deficiency are accompanied by modifications in calcium signaling in hepatocytes such as impairment in inositol-1,4,5-trisphosphate (IP 3 ) synthesis, IP 3 receptor affin-ity, and in the responsiveness of several Ca 2ϩ -mobilizing hormones and growth factors, which seem related to low receptor affinity and/or to the size of the hormone/drug-sensitive intracellular Ca 2ϩ pools Mailhot et al., 2000) . Hypocalcemia has also been shown to retard the hepatic regenerative process (É thier et al., 1990 ). These observations have raised the hypothesis that the defective regeneration process associated with hypocalcemia is due to defect(s) in the hepatocyte mitogenic signaling pathways (Sikorska et al., 1983; Rixon et al., 1989; É thier et al., 1993; Goupil et al., 1997) . Moreover, in several liver diseases where patients are candidates for liver transplantation, malabsorption of vitamin D and of calcium is suspected as being a major determinant of vitamin D depletion and of its accompanying poor systemic and cellular calcium metabolism. This contention is well illustrated by the increased incidence of secondary hyperparathyroidism and of bone diseases (osteomalacia as well as osteoporosis) in these patients (Krawitt et al., 1977; Kato et al., 1982; Mawer et al., 1985) .
The goals of the present studies were to investigate the 1) role of calcium status on the positive effect of CsA on liver regeneration in vivo by investigating whether CsA could reverse the delay in the regeneration process induced by calcium deficiency, and 2) effect of CsA on intracellular Ca 2ϩ homeostasis in isolated rat hepatocytes in vitro to further understand its mechanism of action.
Materials and Methods

In Vivo Studies
Animal Model and Drug Regimen. Studies were conducted in normal rats (Charles River, St. Constant, QC, Canada) and in rats subjected to vitamin D depletion to induce a state of chronic hypocalcemia as described previously (É thier et al., 1990) . In a subset of hypocalcemic animals, oral calcium supplementation was achieved by providing a 3% calcium gluconate solution as drinking water to normalize circulating Ca 2ϩ (Mailhot et al., 2000) and to investigate the interaction between CsA (Novartis, Montreal, QC, Canada) and the in vivo extracellular Ca 2ϩ concentration. The rationale for the model used rests on previous reports showing that 1) hepatic regeneration is perturbed in vitamin D-depleted hypocalcemic animals but completely restored by either vitamin D 3 or 1,25-dihydroxyvitamin D 3 (calcitriol) administration (É thier et al., 1990) ; 2) oral calcium repletion alone in vitamin D-depleted hypocalcemic rats fully restores DNA synthesis after 2/3 partial hepatectomy (É thier et al., 1990) ; and 3) chronic hypocalcemia decreases the IP 3 -sensitive Ca 2ϩ pool content and attenuates cellular Ca 2ϩ signaling by known Ca 2ϩ -mobilizing agents, a phenomenon also restored by vitamin D 3 or calcium repletion Mailhot et al., 2000) .
CsA administration was done as reported previously (Provencher et al., 1999) . Briefly, a dose of 3.33 mg/kg/day CsA (diluted in olive oil and administered intraperitoneally) was given for a period of 10 days before 2/3 partial liver resection. Drug administration was continued at the same dose during the postresection period. Placebo-treated controls received the vehicle only and were subjected to the same experimental regimen as CsA-treated rats. Partial hepatectomy was performed under light ether anesthesia after pretreatment with CsA or placebo. A 2-cm abdominal midline incision was performed and the median and left lobes of the liver were extruded and excised (2/3 partial hepatectomy), or returned to the abdominal cavity (sham operation). The animals were then returned to their cages and had access to food and water ad libitum.
All the animals used in this study were treated in accordance with the standards of ethics for animal experimentation of the Canadian Council on Animal Care. All protocols were approved by a local animal ethics committee.
All chemicals, unless other wise mentioned, were purchased from Sigma-Aldrich Canada (Oakville, ON, Canada (É thier et al., 1990) .
In Vitro Studies. To investigate the influence of CsA on the hepatic compensatory growth process, hepatocytes were obtained from livers of nonfasting normal rats, as described previously (Gascon-Barré et al., 1997). The freshly isolated hepatocytes were equilibrated in William E medium (Invitrogen, Burlington, ON, Canada), and cells were allowed to attach on collagen-coated coverslips (Fisher Scientific, Montreal, QC, Canada) during a period of 1 h at 37°C in 5% CO 2 atmosphere. Before calcium measurements, hepatocytes were exposed to 0, 0.1, 1.0, or 10 g/ml CsA for a period of 30 min in medium containing Ca 2ϩ concentrations similar to those observed in normocalcemia in vivo (1.25 mM Ca 2ϩ ) or in Ca 2ϩ -free medium.
Intracellular Calcium Measurements
Cytoplasmic Ca 2؉ Measurements at Single Cell Level. Hepatocytes were loaded with 2 M Fura-2/AM (Molecular Probes, Eugene, OR) for 30 min at 20°C. Dye-loaded cells were then transferred to a 10-l plastic chamber on the stage of an inverted microscope (Nikon Diaphot; Nikon, Tokyo, Japan) equipped for epifluorescence measurement. All test compounds were superfused at a rate of 3 ml/min in calcium-free Krebs-Henseleit solution, pH 7.4, equilibrated with O 2 /CO 2 (95:5, v/v). Intracellular calcium ([Ca 2ϩ ] i ) measurements were made at the single cell level using an MCID dual excitation spectrofluorometer system (Imaging Research, St. Catherines, ON, Canada) and a refrigerated camera (C4880; Hamamatsu Photonics, Hamamatsu City, Japan), as described previously (Gascon- Mailhot et al., 2000) .
IP 3 -Sensitive Ca 2؉ Pools. IP 3 -sensitive cellular pools were evaluated as described previously (Hofer et al., 1998) . Briefly, Ca 2ϩ content was monitored using 5 g of mag-Fura-2/AM (Molecular Probes) as probe. After mag-Fura-2/AM loading (40 min at 20°C), hepatocytes were exposed to 100 g of saponin/ml for a period of 1 min in a calcium-free buffer containing 125 mM KCl, 25 mM NaCl, 10 mM HEPES, 0.1 mM MgCl 2 , and 1 mM ATP, pH 7.3, at 37°C to achieve plasma membrane permeabilization. Ca 2ϩ mobilization from internal pools was achieved by applying 10 g of IP 3 in the buffer described above but in the absence of saponin. Fluorescence signals were obtained at the single cell level using the imaging system described above to measure cytoplasmic Ca 2ϩ concentrations. Data are presented as the signal ratios obtained at 340 and 380 nm.
Statistical Analysis. Results are expressed as means Ϯ S.E.M. The qualitative evaluation of the time at which peak [ 3 H]thymidine incorporation into DNA occurred was done using a cubic spline equation. Statistically significant differences between group means were evaluated by analysis of variance, or by the Student's t test as indicated in the table and figure legends.
Results
Effect of CsA on Parameters of Vitamin D and Calcium Metabolism
As illustrated in Fig. 1 , CsA significantly increased circulating calcitriol concentrations in normal rats at all time points during CsA exposure, whereas it significantly decreased that of its precursor 25(OH)D 3 , particularly after 3 days of CsA exposure.
Vitamin D depletion significantly decreased both 25(OH)D 3 and calcitriol concentrations. CsA administration, however, did not significantly influence the circulating concentrations of 25(OH)D 3 or calcitriol in vitamin D-depleted rats with serum calcitriol concentrations of 119 Ϯ 3 pmol/l before CsA administration, and 134 Ϯ 28 and 165 Ϯ 35 pmol/l after 9 and 12 days of CsA exposure. Serum 25(OH)D 3 concentrations were similarly unaffected by CsA with circulating concentrations of 5.3 Ϯ 0.4 and 4.6 Ϯ 0.3 M before and after 12 days of CsA administration. Vitamin D depletion, however, led to frank hypocalcemia (0.86 Ϯ 0.08 mM), which was fully normalized by oral calcium feeding (1.27 Ϯ 0.03 compared with 1.3 Ϯ 0.03 mM in normal rats, N.S.).
At the time of euthanasia, no signs of toxicity or intolerance (such as peritonitis) were observed in the CsA-treated animals. CsA administration did not significantly affect the circulating concentrations of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and ionized calcium. Body weight and liver weight were also unaffected by CsA pretreatment. Figure 2A presents 3 H]thymidine incorporation into DNA. This apparent acceleration in DNA synthesis was entirely due to the magnitude of the response at the 20-h time point as indicated by the highly significant difference between the CsA-and placebo-treated groups (p Ͻ 0.003) (Fig. 2A) . The acceleration effect of CsA on the regeneration process was also qualitatively evaluated by cubic spline analysis. It was estimated that peak DNA synthesis occurred 20.3 h after liver resection in CsA-treated compared with 22.9 in control rats. Liver weight restitution was found to be similar in both groups during the time frame studied (Fig. 2B) .
Effect of CsA on Regeneration Process
As expected, hypocalcemia (Fig. 3A) significantly impaired the regeneration process, an impairment not restored to the level of normal placebo-controls by CsA pretreatment. Moreover, CsA administration did not accelerate [ 3 H]thymidine incorporation into DNA nor did it lead to a significant or persistent effect on the magnitude of the response as judged by analysis of variance (Fig. 3A) as well as by the evaluation of the cumulative [ 3 H]thymidine incorporation into DNA over the entire 48 h studied.
Normalization of the circulating calcium concentration alone in vitamin D-depleted rats accelerated DNA synthesis 3 H]thymidine incorporation into cellular DNA in sham-operated and 2/3 partially hepatectomized rats. PHx: CsA, ‚----‚; PHx: placebo, F--F; sham-operated: CsA, ‚ ⅐ ⅐ ⅐ ‚; sham-operated: placebo, F ⅐ ⅐ ⅐ F. CsA was administered for 10 days before PHx or sham operation. Placebo-treated rats received olive oil; n ϭ 3 (sham) to 13 animals (PHx)/group. Statistically significant differences between control and CsA-treated rats were analyzed by two-way analysis of variance, p Ͻ 0.05. Pairwise comparisons between group means at each time point were evaluated by the Student's t test using the Bonferroni/ Dunn correction; ‫,ءء‬ p Ͻ 0.003. B, [
3 H]thymidine incorporation patterns were also evaluated by cubic spline equations with peak DNA synthesis estimated to occur at 20.3 h after HPx in CsA-treated compared with 22.9 in control rats. Liver weight restitution after 2/3 partial hepatectomy: CsA-treated ‚ and placebo-treated F. Statistically significant differences between group means at each time point after PHx were analyzed by the Student's t test, N.S.
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Provencher and Gascon-Barré at ASPET Journals on November 4, 2017 jpet.aspetjournals.org compared with their hypocalcemic counterparts. Calcium supplementation, however, completely abrogated the stimulatory effect of CsA treatment on the pattern and magnitude of the DNA synthesis response (Fig. 3C) . CsA had no significant effect on liver weight restitution compared with placebo-treated rats in either hypo-or normocalcemic vitamin D-depleted rats (Fig. 3, B and D, respectively) .
Effect of CsA Exposure on Intracellular Ca
2؉
Cytoplasmic Ca 2؉ Concentrations. Figure 4 (Fig. 4A) as well as in Ca 2ϩ -free medium (Fig. 4B ). As illustrated, in both cases, CsA led to a dose-dependent increase in basal resting cytoplasmic Ca 2ϩ concentrations, which reached statistical significance at the 1-and 10-g/ml doses of CsA. However, at the 10-g/ml dose of CsA, the mean cytoplasmic Ca 2ϩ concentration was found to be higher in calcium-free medium than in normal extracellular Ca 2ϩ concentration, suggesting a translocation of Ca 2ϩ from intracellular pools to the cytoplasmic compartment (p Ͻ 0.0001).
As illustrated in Figs. 5 and 6, in the presence of normal extracellular calcium, CsA exposure led to a significant increase in Ca 2ϩ mobilization by phenylephrine (Figs. 5A and 6A), vasopressin (Figs. 5B and 6B), as well as EGF (Figs. 5C and 6C) at the 10-g/ml dose. In the absence of extracellular calcium, however, Ca 2ϩ mobilization was only increased by phenylephrine (Figs. 5D and 6D ) to a level, however, 54% lower than that observed in the presence of normal Ca 2ϩ in the extracellular milieu (p Ͻ 0.0001). CsA exposure had no effect on intracellular Ca 2ϩ mobilization by vasopressin (Figs (Figs. 7B and 8A, b) . This observation is consistent with the observed lower agonist-stimulated Ca 2ϩ mobilization presented in Figs. 5 and 6. The IP 3 -mobilizable Ca 2ϩ was shown to be increased at the 0.1-, 1.0-, and 10-g/ml doses of CsA (Figs. 7A and 8B, a) in the presence of extracellular Ca 2ϩ , and at the 1.0-and 10-g/ml doses of CsA (Figs. 7B and 8B, b) in the absence of extracellular Ca 2ϩ . Upon withdrawal of IP 3 and application of 1 mM Ca 2ϩ , an expected increase in the cellular Ca 2ϩ pools was observed in both groups (Fig. 7, A  and B) , illustrating the adequacy of the experimental preparations. 
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Discussion
Our data indicate that, in normal rats, CsA increased hepatic DNA synthesis after 2/3 partial hepatectomy. The most striking difference between CsA-and placebo-treated animals was, not only, the intensity of the response but also an acceleration and a sharpening in peak DNA synthesis. This observation clearly suggests that the drug mediated an increase in the progression through the G 1 /S phase(s) of the cell cycle and reinforce an earlier observation where CsA was shown to intensify the regeneration gradient (Garcia-Alonso et al., 1990) . This phenomenon was not, however, observed in hypocalcemic animals in which a defective regeneration process and hyporesponsiveness to EGF have been shown to occur. Surprisingly, vitamin D-depleted rats fed a high-calcium diet were not responsive to CsA, despite a complete reversal of the EGF hyporesponsiveness by calcium feeding (É thier et al., 1990; Bilodeau et al., 1995) , and the reestablishment of normal DNA synthesis as shown in the present studies. These observations illustrate not only that calcium is an important mediator of DNA synthesis in the regeneration model associated with partial liver resection but also that CsA cannot superimpose its stimulatory effect on the calcium effect.
Although CsA has been shown to influence calcium metabolism in several ways, the mechanisms by which the ion mediates the action of CsA on compensatory hepatic hyperplasia is not known. In the present studies, CsA has been shown to influence calcium homeostasis in vivo by mediating an early and sustained increase in the concentrations of the calcium-regulating hormone calcitriol as well as by influencing the hepatocyte resting and stimulated cytoplasmic Ca 2ϩ responses and the size of the mobilizable IP 3 -sensitive Ca 2ϩ pools in vitro. Other investigators have also reported that CsA plays a role in calcium signaling as illustrated by an increase in the overall Ca 2ϩ content in hepatocytes (Nicchitta et al., 1985 ), a reduction in the level of the calcitriol-depen- jpet.aspetjournals.org dent 28-kDa calcium binding protein despite increases in calcitriol synthesis (Stein et al., 1991; Steiner et al., 1996) , a potentiating effect of known Ca 2ϩ agonists such as vasopressin and phenylephrine on the cellular Ca 2ϩ response in kidney mesengial cells (Skorecki et al., 1992) and C6 glioma cells (Ikesue et al., 2000) , an enhancement at the IP 3 receptor (without increases in IP 3 production) of agonist-induced cellular Ca 2ϩ mobilization in kidney cells (Gordjani et al., 2000) , and an induction of a hepatic hypermetabolic state associated with increases in [Ca 2ϩ ] i mobilization and prostaglandin G 2 synthesis in Kupffer cells (Zhong et al., 2001 ). In addition, CsA has been shown to increase the synthesis and release of potent calcium agonists such as endothelin and norepinephrine and to augment their reactivity in vivo (Moss et al., 1985; Scherrer et al., 1990; Bunchman and Brookshire, 1991; Takeda et al., 1992) .
Whether CsA acts as a hepatomodulator of compensatory growth via a calcium-mediated mechanism is still uncertain but Ca 2ϩ has been demonstrated to be essential for the normal cell cycle progression (Lu and Means, 1993) , whereas several Ca 2ϩ -mobilizing agents have been reported to positively influence hepatic compensatory growth. For example, norepinephrine has not only been shown to increase [Ca 2ϩ ] i mobilization but also to stimulate the hepatic regeneration process via an ␣ 1 -adrenergic receptor-mediated signaling pathway and as such to act as a comitogen in hepatocytes (Cruise et al., 1985; Michalopoulos and DeFrances, 1997) . In addition, several growth factors (EGF/transforming growth factor ␣, hepatocyte growth factor, acidic fibroblast growth factor, which are considered complete liver mitogens and known cellular Ca 2ϩ mobilizers) are essential for the hepatic compensatory growth process, but their role in the CsAmediated effect on DNA synthesis in the regenerating liver has not been investigated (Michalopoulos and DeFrances, 1997) . Mazzaferro et al. (1990) have suggested that CsA seems to have an effect similar to that of insulin, a permissive but incomplete hepatic mitogen, an observation analogous to that proposed for ␣ 1 -adrenergic agents. The data obtained during the present studies are entirely in agreement with the latter suggestion because they unequivocally show that CsA does not have any effect on hepatic DNA synthesis in animals not subjected to partial hepatectomy, hence clearly showing that CsA is not a complete hepatic mitogen.
To investigate the potential role of changes in cellular Ca 2ϩ homeostasis in the CsA-induced effect on the early hepatic regeneration process, an investigation of the IP 3 -sensitive Ca 2ϩ pools and of the response to Ca 2ϩ -mobilizing agonists known to be either hepatocytic mitogen (EGF) or comitogens (vasopressin and phenylephrine) during the compensatory growth process was undertaken. Data show that CsA induced an extracellular Ca 2ϩ -dependent increase in the IP 3 -sensitive Ca 2ϩ pools. In addition, IP 3 -mediated Ca 2ϩ mobilization was significantly increased at all CsA doses in the presence of extracellular Ca 2ϩ , whereas IP 3 induced significant Ca 2ϩ responses at the 1-and 10-g/ml does of CsA in the absence of extracellular Ca 2ϩ . Interestingly, we have previously shown that repletion of hypocalcemic rats with oral calcium also increased the hepatocyte content of the hormone-sensitive Ca 2ϩ pool as well as that of calreticulin (Mailhot et al., 2000) , a protein known to regulate the functional size of IP 3 -sensitive Ca 2ϩ pools (Bastianutto et al., 1995; Mery et al., 1996) . It is, therefore, possible that the acceleration in DNA synthesis observed in calcium-supplemented animals may be due to the cellular calcium effect induced by the nutritional repletion, an effect that cannot be further increased by CsA exposure.
Our data also indicate that CsA significantly modifies the response to Ca 2ϩ -mobilizing agonists and that the presence of extracellular Ca 2ϩ is essential for the response to vasopressin and EGF, whereas a blunted response to phenylephrine (54% less than in the presence of [Ca 2ϩ ] e ) was still observed at the highest CsA dose in the absence of extracellular Ca 2ϩ . This observation is in accordance with that of others where extracellular Ca 2ϩ has been shown to be essential to the CsA-mediated rise in intracellular Ca 2ϩ . Because it is known that hepatic mitogens such as EGF/TGF␣ and HGF and comitogens such as vasopressin and ␣ 1 -adrenergic Fig. 6 . Influence of CsA exposure on the response to calcium-mobilizing agonists in single rat hepatocytes isolated from normal rat livers and exposed in vitro to CsA in the presence of either 1.25 mM (A-C) or in the absence (D-F) extracellular Ca 2ϩ for a period of 30 min before cellular Ca 2ϩ measurements were made using the Fura-2/AM fluoroprobe. Cytoplasmic Ca 2ϩ determinations were made in two to six rats per group with an average of 64 hepatocytes evaluated per group. Data represent the mean Ϯ S.E.M. Significant differences between group means were evaluated by analysis of variance using the Bonferroni/Dunn test for all post hoc evaluations in relation to the 0 CsA dose. Phenylephrine was applied at a dose 2.5 mM, vasopressin at a dose of 10 nM, and EGF at a dose of 25 ng/ml. ‫,ء‬ p Ͻ 0.05; ‫ءء‬ p Ͻ 0.005; ‫,ءءء‬ p Ͻ 0.0001.
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at ASPET Journals on November 4, 2017 jpet.aspetjournals.org agonists act at the G 0 -G 1 and/or at the early G 1 phase of the cell cycle, a positive CsA-mediated effect on these agents would be expected to translate into an acceleration of the G 1 to S phase of the cell cycle and hence by an earlier peak in DNA synthesis. Our observations indicating that DNA synthesis was accelerated by CsA exposure in normal rats in vivo would concur with the in vitro data, indicating a significant CsA-mediated increased resting as well as in stimulated intracellular Ca 2ϩ mobilization, most particularly in the presence of normal extracellular Ca 2ϩ . Of interest also is the observation that CsA led to a significantly sustained increase in the circulating calcitriol concentrations in normal animals. This increase in serum calcitriol may also have played a role in the intensity of the response to CsA because the hormone has been shown to increase intracellular Ca 2ϩ concentration as well as to accelerate DNA synthesis and liver weight restitution after partial hepatectomy in the rat (É thier et al., 1990; Mailhot et al., 2000) .
Despite the apparent acceleration effect of CsA on DNA synthesis, liver weight restitution was shown not to be influenced by the drug in any of the groups studied at the early time points studied. These observations indicate that the early recovery of liver mass is not significantly influenced by CsA, an observation also made by others where liver weight restitution was studied for longer periods of time (Grant et al., 1988; Kahn et al., 1990; Kapan et al., 1996) . The absence of a sustained effect of CsA on liver mass restitution indicates, contrary to earlier reports, little effect of the drug on the organ recovery, an observation also supported by our previous observations showing that CsA has only a selective effect on the drug metabolism recovery after 2/3 partial hepatectomy (Provencher et al., 1999) . Our data, thus, indicate that the extracellular calcium status either directly or indirectly via modulation of intracellular homeostasis plays an essential role as mediator of the cellular calcium response after partial hepatectomy. The data are consistent with CsA accelerating the hepatic compensatory growth process by, in part, increasing the hepatocyte Ca 2ϩ pools and the response (B) for a period of 30 min before cellular Ca 2ϩ measurements were made using the mag-Fura-2/AM fluoroprobe. Intracellular Ca 2ϩ measurements were made in three to five rats per group with an average of 82 hepatocytes per group in the presence of 1.25 mM Ca 2ϩ and in two to three rats/group with an average of 40 hepatocytes per group in the absence of extracellular calcium. Data represents the mean Ϯ S.E.M. Significant differences between group means were evaluated by analysis of variance using the Bonferroni/ Dunn test for all post hoc evaluations in relation to the 0 CsA dose. A, basal [Ca 2ϩ ] i in the presence of 1.25 mM [Ca 2ϩ ] e , p Ͻ 0.0001, and in calcium-free medium, N.S. B, IP 3 -induced increases in [Ca 2ϩ ] i : main effect in the presence of 1.25 mM [Ca 2ϩ ] e , p Ͻ 0.0001, and in calcium-free medium, p Ͻ 0.0001. ‫,ء‬ p Ͻ 0.05; ‫,ءء‬ p Ͻ 0.008; ‫,ءءء‬ p Ͻ 0.0001. Fig. 7 . Representative traces illustrating the influence of CsA exposure on the IP 3 -sensitive Ca 2ϩ pools in single rat hepatocytes isolated from normal rat livers. Hepatocytes were exposed to CsA in the presence of 1.25 mM (A) or in the absence (B) of extracellular Ca 2ϩ for a period of 30 min before cellular Ca 2ϩ measurements were made using the magFura-2/AM fluoroprobe. Ň, indicates application; ņ, withdrawal of IP 3 ; Ń, indicates application; ł, withdrawal of calcium.
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